SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-19-008123
Filing Date
2019-02-14
Accepted
2019-02-14 16:19:00
Documents
1
Group Members
ARMEN B. SHANAFELT, PH.D.LV MANAGEMENT GROUP, LLCS. EDWARD TORRESSTEVEN E. HALL, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tv513506_sc13ga.htm SC 13G/A 130956
  Complete submission text file 0001144204-19-008123.txt   132717
Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Filed by) CIK: 0001575852 (see all company filings)

IRS No.: 264769290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746
Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 19606637
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1